New Tech Brings Big Gains to Ancillary Cannabis -THC Therapeutics Inc. (THCT)


May 30, 2019 -- InvestorsHub NewsWire -- via -- While we’ve seen a high level of interest and investment in the cannabis industry, there’s much more to consider than just the primary market.  There’s another highly lucrative market to examine when looking for opportunities to invest - ancillary cannabis companies.


While everyone knows the legal cannabis market is expected to balloon, many overlook these ancillary companies, which are less regulated but featuring just as much growth.  That’s why we’re highlighting THC Therapeutics, Inc. (USOTC: THCT).  THCT also recently differentiated itself when it announced the appointment of Enzo Villani to the Company’s Board of Directors.  Mr. Villani has raised over $500 million in funding from strategic investors, private equity, venture capital, family offices and the public markets during his over twenty-year career.


THCT’s dHydronator® can reduce moisture content of cannabis to 10% in only 10-14 hours.  This is the same reason Aurora just signed $10M deal with EnWave.  THCT received patent protection on 20 claims from the US patent office in March ’19 and will be using their patented designs to carve out their piece of the legal cannabis market expected to reach $146.4 billion by 2025.


Today we are highlighting: THC Therapeutics, Inc. (USOTC: THCT), Tilray, Inc. (NASDAQ: TLRY), Curaleaf Holdings, Inc. (CURLF), Innovative Industrial Properties, Inc. (NYSE: IIPR), and Charlotte's Web Holdings, Inc. (USOTC: CWBHF).


THC Therapeutics, Inc. (USOTC: THCT) (Market Cap: $101.217M; Share Price: $7.35) has developed a sanitizing herb dryer, The dHydronator®.  Their laboratory-proven product is specifically designed for drying and sanitizing freshly harvested cannabis and herbs.  THCT’s product has been tested by two independent laboratories.  The testing covered over 6 strains and 9 independent tests to confirm the findings.  Over the 9 tests and 6 strains, there was a 4% average increase of THC-A*.


The US patent office has accepted ALL 20 claims for the dHydronator®.  The company has received full patent protection for the dHydronator®. This is big.  Start your research today on THCT.



Tilray, Inc. (NASDAQ: TLRY) (Market Cap: $3.971B; Share Price: $40.84) announced their Portugal-based subsidiary recently received a license to manufacture as well as a certification for GMP (Good Manufacturing Practices).  These recent accomplishments will allow the company to license and certify the Portugal-based plant to manufacture and export GMP-certified cannabis (in dried form) as the active ingredient in products used in a medicinal capacity, increase capacity to serve the EU, and venture more broadly into serving international markets.  Tilray focuses on cannabis research, cultivation, processing and distribution.



Curaleaf Holdings, Inc. (CURLF) (Market Cap: $3.134B; Share Price: $9.25) released the news that their sponsorship of industrial hemp research conducted by the University of Connecticut.  The research is considered pioneering and its’ goal is to improve both production levels as well as practices used currently for advancing cultivation.  Research findings could have a significant impact on industry practices.  Curaleaf is a vertically-integrated U.S. cannabis operator with a nationally-recognized brand.   



Innovative Industrial Properties, Inc. (NYSE: IIPR) (Market Cap: $801.166M; Share Price: $81.70) recently closed on the acquisition of a property in Pennsylvania, entering into a long-term lease agreement with a subsidiary of Green Leaf Medical, LLC.  The property will be used for licensed medical cannabis cultivation and processing.  This arrangement allows IIPR to unlock and redeploy capital across an existing multi-state operation to service high demand from patients in the state of Pennsylvania.  Innovative Industrial Properties, Inc. is the real estate investment trust for the medical-use cannabis industry.   



Charlotte's Web Holdings, Inc. (USOTC: CWBHF) (Market Cap: $1.308B; Share Price: $14.04) has announced conditional approval of its’ common shares on the TSX (Toronto Stock Exchange). By gaining a listing on the TSX, it’s expected that the company will be provided a significantly greater level of exposure to capital sources as well as expanded access to investors, and an increase in trading liquidity.  Charlotte’s Web Holdings focuses on production and distribution of hemp-derived CBD extract products used for wellness.



Legal Disclaimer:

This article was written by Regal Consulting, LLC (“Regal Consulting”).  Regal Consulting has agreed to a three-month term consulting agreement with THCT dated 2/14/18.  The agreement calls for 50,000 restricted shares of THCT per month. This agreement has been amended to $20,000 per month, and 55,000 shares per month and extended for twelve months ending 3/18/2020. All payments were made directly by THC Therapeutics, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of.  Regal Consulting also paid one thousand dollars cash to to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice.  This article is based on public information and the opinions of Regal Consulting. THCT was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein.  Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice. legal disclaimer/

Full Legal Disclaimer Click Here.

Contact Information:

Company Name: ACR Communication LLC.

Contact Person: Media Manager


Phone: 1-702-720-6310

Country: United States